Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent

被引:101
作者
Sun, Juan [1 ]
Zhu, Hui [1 ]
Yang, Zhong-Ming [1 ]
Zhu, Hai-Liang [1 ]
机构
[1] Shandong Univ Technol, Sch Life Sci, Zibo 255049, Shandong, Peoples R China
关键词
Quinoline; 1,3,4-Oxadiazole; Antiproliferative; Telomerase inhibitor; Molecular docking; ANTITUMOR; 1,4-BENZODIOXAN; DOCKING; DESIGN; MOIETY;
D O I
10.1016/j.ejmech.2012.11.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of quinoline derivatives (4a-4o) have been synthesized and their biological activities were also evaluated as potential telomerase inhibitors. Bioassay tests demonstrated that most of the compounds exhibited substantial broad-spectrum antitumor activity against the three cancer cell lines (HepG2, SGC-7901 and MCF-7). Moreover, all the title compounds were assayed for telomerase inhibition using the TRAP-PCR-ELISA assay. Compounds 4d and 4i displayed the most potent anticancer activities, which were comparable to the positive control. Docking simulation was performed to position compounds 4d and 4i into the telomerase structure active site to determine the probable binding model. Compounds 4d and 4i with potent inhibitory activity in tumor growth inhibition may be potential anticancer agents. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:23 / 28
页数:6
相关论文
共 28 条
[1]  
Abadi AH, 2003, CHEM PHARM BULL, V51, P838
[2]   Syntheses and antitumor targeting G1 phase of the cell cycle of benzoyldihydroisoquinolines and related 1-substituted isoquinolines [J].
Bermejo, A ;
Andreu, I ;
Suvire, F ;
Léonce, S ;
Caignard, DH ;
Renard, P ;
Pierré, A ;
Enriz, RD ;
Cortes, D ;
Cabedo, N .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (23) :5058-5068
[3]   Synthesis and antifungal activities of 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-thiadiazole and 5(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-oxadiazole derivatives [J].
Chen, Cai-Jun ;
Song, Bao-An ;
Yang, Song ;
Xu, Guang-Fang ;
Bhadury, Pinaki S. ;
Jin, Lin-Hong ;
Hu, De-Yu ;
Li, Qian-Zhu ;
Liu, Fang ;
Xue, Wei ;
Lu, Ping ;
Chen, Zhuo .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (12) :3981-3989
[4]   Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery [J].
Chen, XY ;
Plasencia, C ;
Hou, YP ;
Neamati, N .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (04) :1098-1106
[5]   Synthesis of new Δ2-isoxazoline derivatives and their pharmacological characterization as β-adrenergic receptor antagonists [J].
Conti, P ;
Dallanoce, C ;
De Amici, M ;
De Micheli, C ;
Klotz, KN .
BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (04) :401-408
[6]   Superior reactivity of thiosemicarbazides in the synthesis of 2-amino-1,3,4-oxadiazoles [J].
Dolman, Sarah J. ;
Gosselin, Francis ;
O'Shea, Paul D. ;
Davies, Ian W. .
JOURNAL OF ORGANIC CHEMISTRY, 2006, 71 (25) :9548-9551
[7]  
Eckhardt Sandor, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P419, DOI 10.2174/1568011024606389
[8]   Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors [J].
Flipo, Marion ;
Desroses, Matthieu ;
Lecat-Guillet, Nathalie ;
Villemagne, Baptiste ;
Blondiaux, Nicolas ;
Leroux, Florence ;
Piveteau, Catherine ;
Mathys, Vanessa ;
Flament, Marie-Pierre ;
Siepmann, Juergen ;
Villeret, Vincent ;
Wohlkonig, Alexandre ;
Wintjens, Rene ;
Soror, Sameh H. ;
Christophe, Thierry ;
Jeon, Hee Kyoung ;
Locht, Camille ;
Brodin, Priscille ;
Deprez, Benoit ;
Baulard, Alain R. ;
Willand, Nicolas .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (01) :68-83
[9]   Elucidation of fatty acid amide hydrolase inhibition by potent α-ketoheterocycle derivatives from Monte Carlo simulations [J].
Guimaraes, CRW ;
Boger, DL ;
Jorgensen, WL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (49) :17377-17384
[10]   TELOMERE LOSS - MITOTIC CLOCK OR GENETIC TIME BOMB [J].
HARLEY, CB .
MUTATION RESEARCH, 1991, 256 (2-6) :271-282